Scott Gleason

Scott Gleason is a diagnostics, life sciences, and healthcare executive with approximately 25 years of experience in finance, investor relations, corporate strategy, corporate communications, and equity research. Prior to joining the Company, he served as Vice President, Investor Relations and Treasury, of Neogen Corporation, an international food safety company. Before his role at Neogen, he served as the Chief Financial Officer of NX Prenatal, Inc., a prenatal diagnostic company, and LarmorBio, Inc., a Boston-based life sciences and clinical diagnostics startup. Prior to that, Mr. Gleason served as Interim Chief Financial Officer, Senior Vice President, Investor Relations and Corporate Communications of OraSure Technologies, Inc., a developer and manufacturer of diagnostic tests and sample collection solutions. Before joining OraSure, Mr. Gleason served as Senior Vice President, Investor Relations and Corporate Strategy for Myriad Genetics, Inc., a specialty diagnostics laboratory. Prior to Myriad Genetics, Mr. Gleason was a senior publishing analyst at Stephens Inc., where he covered the life science tools and diagnostics industry. Earlier in his career, he served as a United States Air Force aircraft maintenance officer. Mr. Gleason received a Bachelor of Science degree in Economics from the United States Air Force Academy in Colorado Springs, Colorado.